These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24182611)

  • 1. Functional disorders of the gastrointestinal tract: Cost effectiveness review.
    Mapel DW
    Best Pract Res Clin Gastroenterol; 2013 Dec; 27(6):913-31. PubMed ID: 24182611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rome III classification of functional gastrointestinal disorders in children with chronic abdominal pain].
    Plocek A; Wasowska-Królikowska K; Toporowska-Kowalska E
    Med Wieku Rozwoj; 2010; 14(4):350-6. PubMed ID: 21462479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional dyspepsia: not all roads seem to lead to rome.
    van Kerkhoven LA; Laheij RJ; Meineche-Schmidt V; Veldhuyzen-van Zanten SJ; de Wit NJ; Jansen JB
    J Clin Gastroenterol; 2009 Feb; 43(2):118-22. PubMed ID: 18719513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of competing diagnostic models of functional gastrointestinal disorders related to pain in children.
    Schurman JV; Karazsia BT; Friesen CA
    Neurogastroenterol Motil; 2017 Nov; 29(11):. PubMed ID: 28656703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional gastrointestinal disorders in 2007 and Rome III: something new, something borrowed, something objective.
    Talley NJ
    Rev Gastroenterol Disord; 2007; 7(2):97-105. PubMed ID: 17597677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional gastrointestinal disorders in eating disorder patients: altered distribution and predictors using ROME III compared to ROME II criteria.
    Wang X; Luscombe GM; Boyd C; Kellow J; Abraham S
    World J Gastroenterol; 2014 Nov; 20(43):16293-9. PubMed ID: 25473186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's new in Rome IV?
    Tack J; Drossman DA
    Neurogastroenterol Motil; 2017 Sep; 29(9):. PubMed ID: 28303651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiological concepts of functional dyspepsia and irritable bowel syndrome future pharmacotherapy.
    Dobrek Ł; Thor PJ
    Acta Pol Pharm; 2009; 66(5):447-60. PubMed ID: 19894640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comments on Rome criteria of functional gastrointestinal disorders.
    Maratka Z
    Hepatogastroenterology; 2007 Mar; 54(74):454-7. PubMed ID: 17523297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of dyspepsia and functional gastrointestinal disorders: a cost-benefit analysis of different approaches.
    Sonnenberg A; Townsend WF; Müller AD
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):655-9. PubMed ID: 8590161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definitions and Outcome Measures in Pediatric Functional Upper Gastrointestinal Tract Disorders: A Systematic Review.
    Nassar-Sheikh Rashid A; Taminiau JA; Benninga MA; Saps M; Tabbers MM
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):581-7. PubMed ID: 26348686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rome III: the new criteria.
    Drossman DA
    Chin J Dig Dis; 2006; 7(4):181-5. PubMed ID: 17054578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rome III criteria in parents' hands: pain-related functional gastrointestinal disorders in community children and associations with somatic complaints and mental health.
    Gulewitsch MD; Enck P; Schwille-Kiuntke J; Weimer K; Schlarb AA
    Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1223-9. PubMed ID: 24002016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectra, symptom profiles and overlap of Rome III functional gastrointestinal disorders in a tertiary center in South China.
    Xiong LS; Shi Q; Gong XR; Cui Y; Chen MH
    J Dig Dis; 2014 Oct; 15(10):538-44. PubMed ID: 25102919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study.
    Aziz I; Palsson OS; Törnblom H; Sperber AD; Whitehead WE; Simrén M
    Lancet Gastroenterol Hepatol; 2018 Apr; 3(4):252-262. PubMed ID: 29396034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical economics review: gastrointestinal disease in primary care.
    Jones RH
    Aliment Pharmacol Ther; 1996 Jun; 10(3):233-9. PubMed ID: 8791945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rome III: New standard for functional gastrointestinal disorders.
    Drossman DA; Dumitrascu DL
    J Gastrointestin Liver Dis; 2006 Sep; 15(3):237-41. PubMed ID: 17013448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.